Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sanai Health Industry Group Company Limited ( (HK:1889) ) just unveiled an update.
Sanai Health Industry Group Company Limited has issued a clarification and supplemental announcement regarding its 2023 annual report, correcting the disclosed allocation of net proceeds from its issue of convertible notes. The company now states that it intended to use approximately 45% of the proceeds for production plants, equipment, facilities and raw materials, 30% to enrich its pharmaceutical product base through new drug development and licence acquisitions, and 25% to add sales points and cover additional sales staff costs, confirming that all proceeds had been fully utilised as of 31 December 2022 and that no other information in the annual report is affected by this correction.
More about Sanai Health Industry Group Company Limited
Sanai Health Industry Group Company Limited is a pharmaceutical-focused company engaged in the production and sale of pharmaceutical products, including developing new medicines and acquiring drug licences, and expanding its sales network and production capabilities in relevant healthcare markets.
Average Trading Volume: 437,981
Technical Sentiment Signal: Hold
Current Market Cap: HK$77.98M
Find detailed analytics on 1889 stock on TipRanks’ Stock Analysis page.